Live Breaking News & Updates on Treat Persistent Atrial Fibrillation

Acutus Medical Announces CE Mark Approval for Suite of Next Generation EP Products in Europe
Expanded and Product Portfolio Strengthens Offering in Access and Therapy Guidance
May 12, 2021 16:05 ET
| Source:
Acutus Medical, Inc.
Acutus Medical, Inc.
Carlsbad, California, UNITED STATES
CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced CE Mark Approval for a broad suite of EP products that includes the AcQCross™ family of universal transseptal crossing devices, the next generation AcQGuide
® MAX and VUE large bore delivery sheaths and the next generation AcQMap ....

United States , Acutu Acqmap , Vince Burgess , Holly Windler , Acutus Medical Inc , Millennium Research Group , Heart Rhythm Society Journal , Heart Rhythm Society , Universal Transseptal Access System , Ablation Strategy , Treat Persistent Atrial Fibrillation , Core To Boundary Approach Guided , Charge Density Mapping , Heart Rhythm , Research Group , Electrophysiology Mapping , Ablation Devices , Market Analysis , Acutus Medical , Nasdaq Afib , Acutus Medical , ஒன்றுபட்டது மாநிலங்களில் , வின்ஸ் பர்கஸ் , ஹோலி விண்ட்லர் , மில்லினியம் ஆராய்ச்சி குழு , இதயம் தாளம் சமூகம் ,